Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-06

Clinical Trial Update: Huaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy [Phase 4]

View source ↗

Summary

Phase 4 trial update on Huaier Granule for preventing disease progression after non-radical hepatectomy in hepatic carcinoma; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Huaier Granule

Snippet

Sponsor: Qidong Gaitianli Medicines Co., Ltd | Conditions: Hepatic Carcinoma | Phase 4 | Status: TERMINATED